To view this email as a web page, click here.

CAM Therapies for Epilepsy: A Look at the Pros and Cons

Patients with epilepsy often seek CAM therapies—with or without the recommendation or explicit approval of their neurologist.
Image ©R_Szatkowski/Shutterstock.com

FDA Gives Nod to New Treatment for Episodic Cluster Headache

Emgality (galcanezumab-gnlm) is the first FDA-approved drug that reduces the frequency of cluster headache attacks.
Image © Waldemarus/Shutterstock.com

Make the EHR Selection Process Effortless
Are you searching for a new EHR or implementing one for the first time? It can be overwhelming.

Download the “Shopping for Your New EHR” guide for straightforward advice on how to master the selection process.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.